News und Analysen
DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 44 / 2021) with Fabcon Precast
DGAP-News: RIB Software SE (RIB) unterzeichnet einen Phase-II-Auftrag (Nr. 44 / 2021) mit Fabcon Precast
Iconic Rolling Paper Brand Zig-Zag Announces Launch of Zig-Zag Studio
Zig-Zag and Turning Point Brands, Inc. (NYSE: TPB) announced today the launch of Zig-Zag Studio (or “Studio”), the next chapter of the evolution of content, collaborations and media supporting the
REX American Resources Reports Fiscal 2021 Third Quarter Net Income Per Share Attributable to Rex Common Shareholders Increase of 78% To $2.56
REX American Resources Corporation (NYSE: REX) (“REX” or “the Company”) today reported financial results for its fiscal 2021 third quarter (“Q3 ‘21”) ended October 31, 2021. REX management will
DGAP-News: INDUS Holding AG: INDUS stärkt Portfoliostruktur weiter und verkauft Automobil-Serienzulieferer
DGAP-News: INDUS Holding AG: INDUS continues to strengthen portfolio structure and sells series supplier
Nordic Enterprises Embrace Cloud Services to Improve Customer Experience
Enterprises in the Nordic region are increasing their spending on public cloud services and digital transformation to improve customer experiences, according to a new report published today by
DGAP-News: Vossloh Aktiengesellschaft: Vossloh wins major contract in Turkey for the supply of rail infrastructure components
DGAP-News: Vossloh Aktiengesellschaft: Vossloh gewinnt Großauftrag in der Türkei zur Lieferung von Bahninfrastrukturkomponenten
DGAP-Adhoc: ADLER verkauft ca. 7% der Aktien an der Brack Capital Properties N.V. und verpflichtet sich, die übrigen von ihr gehaltenen Aktien bis zum 30. 09. 2022 in ein öffentliches Erwerbsangebot einzuliefern
DGAP-Adhoc: ADLER sells a c.7% stake in Brack Capital Properties N.V and grants tender commitment for all its remaining shares in BCP until 30 September 2022
Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA)
Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the
EQS-News: Kudelski Security Enriches Managed Detection & Response (MDR) Services with Integration of Microsoft Defender for Endpoint
U.K. Enterprises Seek Help with ‘Cloud-First’ Approach
Enterprises in the U.K. are increasingly embracing a cloud-first approach to their IT investments and are looking to service providers to help them migrate more of their workloads to the public
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope
Simulations Plus, Inc. (Nasdaq: SLP) is celebrating 25 years in business and continuing the commitment to improve public health through innovative solutions with a $25,000 donation to the
MaxLinear Announces Stock Exchange Listing Transfer to Nasdaq
MaxLinear, Inc. (NYSE: MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced that it will voluntarily transfer its stock exchange
Deciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial Operations
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced a corporate
Synalloy Announces Commencement of Rights Offering
Synalloy Corporation (Nasdaq: SYNL) (“Synalloy” or the “Company”), an industrials company focused on the production and distribution of piping, tubing and specialty chemicals, today announced that
DGAP-News: LPKF eröffnet Biolabor für die ARRALYZE-Technologie
DGAP-News: LPKF Opens Biolab for ARRALYZE Technology
IMV Announces First Patient Dosed in Phase 1b Clinical Study Evaluating its Lead Compound in Patients with Breast Cancer
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and blood cancers while preserving
RRD Confirms Receipt of Revised Proposal from Chatham Asset Management
R.R. Donnelley & Sons Company (NYSE: RRD) (“RRD” or the “Company”) today announced that it has received a proposal from Chatham Asset Management, LLC ("Chatham") to acquire all of the outstanding
Perion’s Black Friday eCommerce Search Volume Breaks Previous Record, Despite Overall Online Sales Dip
Perion Network Ltd. (NASDAQ: PERI), a global advertising technology company that delivers a holistic solution across the three main pillars of digital advertising – ad search, social media, and